Genetic Information Improves Prognosis And Relapse-Free Survival Prediction For Breast Cancer Patients
According to an article published in JAMA, doctorswho breast cancer patients and integrate gene expressionsignatures with clinical and other risk factors may be better atpredicting a patient’s response to chemotherapy. Chaitanya R.Acharya, M.S. (Duke Institute for Genome Sciencesand Policy, Duke University, Durham, N.C.) and colleagues also findthat the genetic information helps to refine estimates of relapse-freesurvival.
More: continued here